Related Experiment Video
Updated: Aug 12, 2026

12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
[Cyclic GMP in the eye and its correlation with externally administered insulin]
Journal Francais D'Ophtalmologie
|February 1, 1979
Summary
Local insulin administration to rabbit eyes increases cyclic GMP (cGMP) levels in ocular tissues. Intravenous insulin, however, shows no effect on cGMP concentrations in the eye or blood serum.
Area of Science:
- Ophthalmology
- Neuroscience
- Biochemistry
Context:
- Cyclic GMP (cGMP) is a crucial second messenger in various physiological processes, including ocular functions.
- Understanding the regulation of cGMP in the eye is essential for developing targeted therapies for visual disorders.
- Insulin's role in ocular physiology beyond glucose metabolism is an area of ongoing research.
Purpose:
- To investigate the effect of local versus systemic insulin administration on cyclic GMP (cGMP) levels in different eye tissues.
- To identify the specific ocular tissues responsible for cGMP synthesis and regulation in response to insulin.
Summary:
- Albino rabbits were used to detect cGMP in eye tissues and assess insulin's influence.
- Retrobulbar insulin injection significantly increased cGMP levels in aqueous humor, lens, vitreous body, and blood serum within 3-10 minutes.
- Intravenous insulin administration did not alter cGMP concentrations in these tissues, suggesting a localized effect.
Impact:
- The retina and choroid appear to be the primary sites of cGMP production within the eye.
- Findings suggest a localized mechanism by which insulin influences ocular cGMP levels.
- This research may inform novel therapeutic strategies for eye conditions involving cGMP dysregulation.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

